GLENMARK LIFE SCIENCES
Back to Balance Sheet
|
GLENMARK LIFE SCIENCES Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹1,477 Cr | ₹1,354 Cr | ₹1,381 Cr | ₹178 Cr | ₹-147 Cr |
What is the latest Net Current Assets ratio of GLENMARK LIFE SCIENCES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹1,477 Cr |
Mar2023 | ₹1,354 Cr |
Mar2022 | ₹1,381 Cr |
Mar2021 | ₹178 Cr |
Mar2020 | ₹-147 Cr |
How is Net Current Assets of GLENMARK LIFE SCIENCES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹1,477 Cr | 9.12 | |
Mar2023 | ₹1,354 Cr | -1.94 | |
Mar2022 | ₹1,381 Cr | 677.35 | |
Mar2021 | ₹178 Cr | Positive | |
Mar2020 | ₹-147 Cr | - |
Compare Net Current Assets of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,139.4 Cr | -0.6% | 7% | 70.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | -1.3% | -4.8% | 45% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,923.0 Cr | 0.5% | 6.4% | 58.2% | Stock Analytics | |
CIPLA | ₹121,796.0 Cr | 2.1% | 3.8% | 24.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,919.0 Cr | -0.6% | -5.7% | 5.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,072.6 Cr | 0.1% | -3.6% | 48.2% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -0.6% |
7% |
70.9% |
SENSEX | 0.2% |
-0.2% |
21.6% |
You may also like the below Video Courses